Related Experiment Videos
Intravenous valproate in neuropsychiatry.
1Department of Neurology, University of Mississippi College of Medicine, Jackson, USA.
Pharmacotherapy
|January 21, 2000
Summary
Intravenous valproate offers a rapid treatment option for patients unable to take oral medications. This well-tolerated therapy shows promise for various neuropsychiatric disorders beyond epilepsy.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Valproic acid (VPA) is a widely used antiepileptic drug.
- Intravenous valproate (valproate) is established for status epilepticus treatment.
- Limited data exists on intravenous valproate for non-epileptic neuropsychiatric conditions.
Observation:
- Intravenous valproate was administered to three patients with neuropsychiatric disorders.
- This route bypasses oral administration challenges.
- It allows for rapid achievement of therapeutic serum levels.
Findings:
- Successful administration of intravenous valproate in three patients with neuropsychiatric disorders.
- Intravenous valproate is a viable alternative for patients with oral administration issues.
- The treatment was well-tolerated by the patients.
Implications:
- Increased awareness of intravenous valproate as a treatment option for neuropsychiatric disorders.
- Potential for broader clinical application of intravenous valproate.
- Highlights the utility of parenteral administration for rapid therapeutic intervention.